Trials

  • CERC Trial

    DESyne BDS Plus RCT

    -

    The DESyne BDS Plus Randomised Clinical Trial (RCT) will seek to evaluate the safety, effectiveness and performance of the DESyne BDS Plus DECSS (Test) as compared to the CE Mark approved DESyne X2 Novolimus Eluting Coronary Stent System (DESyne X2 NECSS; DESyne X2) (Control) in the treatment of de...

  • CERC Trial

    DynamX Sprint BTK

    -

    Randomized clinical trial (RCT) comparing outcomes of the DynamX Sprint BTK Bioadaptor to Percutaneous Transluminal Angioplasty (PTA) for the treatment of Below the Knee (BTK) infrapopliteal arteries.

  • CERC Trial

    E-ULTRA 10K

    -

    eUltra 10k is a post market, prospective, observational, multicenter registry aimed at evaluating the non-inferiority of BioFreedomTM Ultra CoCr Biolimus A9 (BA9)TM coated coronary stent in patient with coronary artery disease treated by Percutaneous Coronary Intervention.

  • CERC Trial

    EBC DCB

    -

    The European Bifurcation Club randomized trial of stepwise provisional stenting versus Drug Coated Balloon Therapy for non-left main true coronary bifurcations Legal Representative of Sponsor in European Union: CERC Investigator Initiated Trial The EBC DCB study is an investigator initiated, multi...

  • CERC Trial

    EESIS-FR

    -

    This is a multicentre post marketing study in France evaluating the safety and efficacy of the eCLIPs™ Family of Products for the treatment of bifurcation intracranial aneurysms at the carotid and basilar terminus. The eCLIPs device is the first neuro device that has gained Innovation funding (in...

  • CERC Trial

    ELECTRODUCER

    -

    The objective of this trial is to assess the peri procedural safety of ELECTRODUCER SLEEVE device used for temporary cardiac pacing during percutaneous cardiovascular interventions, by radial and femoral routes of access. This is a pilot, prospective, multi-center, non-comparative study in 60...

  • CERC Trial

    EucaLimus Post-Market Registry

    -

    Single-arm, Prospective, Open label, All Comers, Multicenter Registry. The objective is to assess safety and performance of EucaLimus, a sirolimus eluting PTCA stent system, in a prospective study as part of the manufacturer‘s post-market surveillance program

  • CERC Trial

    EuroNetrod HTN OFF-Med

    -

    EuroNetrod HTN OFF-Med Study is a multi-center blinded, 3-arm randomized (2:1:1) controlled investigation that aims to evaluate the efficacy and safety of the Netrod™ RDN system in patients with uncontrolled primary hypertension in the absence of antihypertensive medication, comparing the outcomes...

  • CERC Trial

    EVERGREEN

    -

    Evaluation of the Valiant Captivia Physician fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies (EVERGREEN) EVERGREEN study is a prospective, multi-center, multinational, single arm study. The objective is to evaluate the safety and effectiveness of Valiant...

  • CERC Trial

    GLYCAR

    -

    GLYCAR STUDY is a Post Market Multicenter clinical investigation of GLYCAR Bovine pericardial patch with EnCap™ Technology in cardiac and vascular repair or reconstruction surgery. The main objective of this study is to collect real-world, long term clinical data in 100 adult and pediatric patients...